Zebin Wang
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Papers in
- Oncology 14
- PARP inhibition in cancer therapy 6
- Inflammatory Biomarkers in Disease Prognosis 2
-
- Parathyroid Disorders and Treatments 4
- Renal Diseases and Glomerulopathies 3
- Co-authors
- Pradip Raychaudhuri (10 shared papers)Janai R. Carr (7 shared papers)Nissim Hay (5 shared papers)Hyun Jung Park (5 shared papers)Angela L. Tyner (8 shared papers)Robert H. Costa (4 shared papers)Qi Wang (2 shared papers)Krushna Chandra Patra (2 shared papers)
- Journals
- Cancer Research (4 papers)Renal Failure (4 papers)Oncotarget (3 papers)Cancer Cell (2 papers)Journal of the American Oil Chemists Society (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Zebin Wang
47 papers receiving 2.4k citations
Zebin Wang's Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 638
- Oncology 708
- Molecular Biology 1.5k
- Aging 21
- Pathology and Forensic Medicine 176
Countries citing papers authored by Zebin Wang
This map shows the geographic impact of Zebin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zebin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zebin Wang more than expected).
Fields of papers citing papers by Zebin Wang
This network shows the impact of papers produced by Zebin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zebin Wang. The network helps show where Zebin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zebin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer Hit paper breakdown → | 2013 | 718 |
| 2 | 2019 | 205 | |
| 3 | 2009 | 202 | |
| 4 | 2010 | 160 | |
| 5 | 2018 | 138 | |
| 6 | 2010 | 125 | |
| 7 | 2009 | 89 | |
| 8 | 2011 | 84 | |
| 9 | 2015 | 79 | |
| 10 | 2012 | 65 | |
| 11 | 2013 | 56 | |
| 12 | 2010 | 55 | |
| 13 | 2022 | 44 | |
| 14 | 2013 | 41 | |
| 15 | 2018 | 38 | |
| 16 | 2013 | 30 | |
| 17 | 2021 | 28 | |
| 18 | 2014 | 25 | |
| 19 | 2011 | 25 | |
| 20 | 2013 | 22 |
About Zebin Wang
Zebin Wang is a scholar working on Oncology, Nephrology, Molecular Biology, Cancer Research and Cell Biology, having authored 49 papers that have together received 2.4k indexed citations. Recurring topics across this work include FOXO transcription factor regulation (9 papers), PARP inhibition in cancer therapy (6 papers), Parathyroid Disorders and Treatments (4 papers), Pancreatic function and diabetes (3 papers), Renal Diseases and Glomerulopathies (3 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Signaling Pathways in Disease (2 papers). The work is most often cited by research in Cancer Research (638 citations), Oncology (708 citations), Molecular Biology (1.5k citations), Aging (21 citations) and Pathology and Forensic Medicine (176 citations). Zebin Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Pradip Raychaudhuri, Janai R. Carr, Nissim Hay, Hyun Jung Park, Angela L. Tyner, Robert H. Costa, Qi Wang, Krushna Chandra Patra, Abhishek Jha and Markku Laakso. Their work appears in journals such as Cancer Research, Renal Failure, Oncotarget, Cancer Cell and Journal of the American Oil Chemists Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.